Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs

The development of multidrug resistance (MDR) in cancer patients driven by the overexpression of ATP-binding cassette (ABC) transporter ABCB1 or ABCG2 in cancer cells presents one of the most daunting therapeutic complications for clinical scientists to resolve. Despite many novel therapeutic strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chung-Pu, Hsiao, Sung-Han, Huang, Yang-Hui, Hung, Lang-Cheng, Yu, Yi-Jou, Chang, Yu-Tzu, Hung, Tai-Ho, Wu, Yu-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017071/
https://www.ncbi.nlm.nih.gov/pubmed/31941029
http://dx.doi.org/10.3390/cancers12010195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017071/
https://www.ncbi.nlm.nih.gov/pubmed/31941029
http://dx.doi.org/10.3390/cancers12010195

Ejemplares similares